ExpreS2ion Biotech Holding AB (publ)

OM:EXPRS2 Stock Report

Market Cap: kr133.7m

ExpreS2ion Biotech Holding Management

Management criteria checks 2/4

ExpreS2ion Biotech Holding's CEO is Bent Frandsen, appointed in Dec 2019, has a tenure of 4.33 years. directly owns 0.96% of the company’s shares, worth SEK1.28M. The average tenure of the management team and the board of directors is 3.3 years and 5 years respectively.

Key information

Bent Frandsen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.3yrs
CEO ownership1.0%
Management average tenure3.3yrs
Board average tenure5yrs

Recent management updates

Recent updates

We're Keeping An Eye On ExpreS2ion Biotech Holding's (STO:EXPRS2) Cash Burn Rate

Mar 07
We're Keeping An Eye On ExpreS2ion Biotech Holding's (STO:EXPRS2) Cash Burn Rate

ExpreS2ion Biotech Holding (STO:EXPRS2) Shareholders Have Enjoyed A Whopping 349% Share Price Gain

Feb 08
ExpreS2ion Biotech Holding (STO:EXPRS2) Shareholders Have Enjoyed A Whopping 349% Share Price Gain

CEO Compensation Analysis

How has Bent Frandsen's remuneration changed compared to ExpreS2ion Biotech Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-kr96m

Sep 30 2023n/an/a

-kr125m

Jun 30 2023n/an/a

-kr136m

Mar 31 2023n/an/a

-kr131m

Dec 31 2022n/an/a

-kr119m

Sep 30 2022n/an/a

-kr84m

Jun 30 2022n/an/a

-kr63m

Mar 31 2022n/an/a

-kr47m

Dec 31 2021kr2mkr2m

-kr44m

Compensation vs Market: Insufficient data to establish whether Bent's total compensation is reasonable compared to companies of similar size in the Swedish market.

Compensation vs Earnings: Insufficient data to compare Bent's compensation with company performance.


CEO

Bent Frandsen

4.3yrs

Tenure

kr1,962,000

Compensation

Mr. Bent U. Frandsen, MSc, has been Chief Executive Officer at ExpreS2ion Biotech Holding AB since December 20, 2019. He serves as Chief Executive Officer at ExpreS2ion Biotechnologies ApS. He served as Vi...


Leadership Team

NamePositionTenureCompensationOwnership
Bent Frandsen
Chief Executive Officer4.3yrskr1.96m0.96%
SEK 1.3m
Keith Alexander
Chief Financial Officer3.5yrsno data0.068%
SEK 91.0k
Max Sogaard
Senior Vice President of Research & Development and Technology3.1yrsno data0.15%
SEK 193.9k
Farshad Guirakhoo
Chief Scientific Officer1.3yrsno datano data

3.3yrs

Average Tenure

Experienced Management: EXPRS2's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jakob Knudsen
Independent Director7yrskr108.00k0.037%
SEK 49.2k
Martin Jensen
Chairman of the Board14.3yrskr199.00k1.15%
SEK 1.5m
Karin Garre
Independent Director2.9yrskr54.00kno data
Sara Sande
Independent Director2.9yrskr54.00k0.0078%
SEK 10.4k

5.0yrs

Average Tenure

59yo

Average Age

Experienced Board: EXPRS2's board of directors are considered experienced (5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.